ArticleNeural regeneration research2026
Delta9-tetrahydrocannabinol: A blunt weapon or a double-edged sword for virus-induced neuroinflammation.
Alison R Van Zandt, Miranda D Horn, Andrew G MacLean
Abstract read
In one paragraphArticle in Neural regeneration research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
3 authors.
Alison R Van ZandtTulane National Biomedical Research Center, Tulane University, Covington, LA, USA (Van Zandt AR, Horn MD, MacLean AG).
Miranda D HornTulane National Biomedical Research Center, Tulane University, Covington, LA, USA (Van Zandt AR, Horn MD, MacLean AG).
Andrew G MacLeanTulane National Biomedical Research Center, Tulane University, Covington, LA, USA (Van Zandt AR, Horn MD, MacLean AG).ORCID 0000-0002-0356-0674 Funding
Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4MViral Testing CoreU42OD024282 · OD · TULANE UNIVERSITY OF LOUISIANA · PI KASI E RUSSELL-LODRIGUE · 2017 to 2026
$25.7MViral Testing Core - Maintenance of an SPF Macaque Breeding Colony for AIDS ResearchU42OD010568 · OD · TULANE UNIVERSITY OF LOUISIANA · PI KASI E RUSSELL-LODRIGUE · 2013 to 2026
$21.7MEradication of latent SIV from the CNSR01NS104016 · NINDS · TULANE UNIVERSITY OF LOUISIANA · PI LING, BINHUA "JULIE", MACLEAN, ANDREW G · 2017 to 2021
$3.7MExploratory Research on HIV Contribution to Heart and Lung ComorbiditiesR01HL152804 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI MACLEAN, ANDREW G · 2020 to 2023
$2.4MExosome Origin in HIV PathogenesisR21MH113517 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI MACLEAN, ANDREW G · 2017 to 2018
$470kReducing the CNS reservoir through myeloid cell depletionR21MH125716 · NIMH · TULANE UNIVERSITY OF LOUISIANA · PI MACLEAN, ANDREW G · 2021 to 2022
$468kNHLBI NIH HHS R01 HL152804NIH HHS P51 OD011104NIH HHS U42 OD010568NIH HHS U42 OD024282NIMH NIH HHS R21 MH113517NIMH NIH HHS R21 MH125716NINDS NIH HHS R01 NS104016
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID41495623
PMCPMC13557690
What OpenQuestion holds
Textmetadata
Read underepoch 390